Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine
出版年份 2019 全文链接
标题
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 68, Issue 11, Pages 1791-1804
出版商
Springer Science and Business Media LLC
发表日期
2019-10-17
DOI
10.1007/s00262-019-02411-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab
- (2019) M. Christina Cox et al. CLINICAL CANCER RESEARCH
- Follicular lymphoma: 2018 update on diagnosis and management
- (2018) Arnold Freedman AMERICAN JOURNAL OF HEMATOLOGY
- Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients
- (2018) Marzia Palma et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
- (2018) Franck Morschhauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
- (2017) Manh-Cuong Vo et al. EXPERIMENTAL HEMATOLOGY
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
- (2017) Manh-Cuong Vo et al. Oncotarget
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
- (2017) B. Montico et al. OncoImmunology
- Dendritic Cell Therapies for Hematologic Malignancies
- (2017) Matthew Weinstock et al. Molecular Therapy-Methods & Clinical Development
- Changes in regulatory T-cells in responding and non-responding patients with indolent B-cell or mantle cell lymphomas during treatment with lenalidomide, dexamethasone, and rituximab.
- (2017) N. Aqui et al. JOURNAL OF CLINICAL ONCOLOGY
- Follicular lymphoma: evolving therapeutic strategies
- (2016) B. S. Kahl et al. BLOOD
- Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
- (2016) Clémentine Sarkozy et al. JOURNAL OF CLINICAL ONCOLOGY
- NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
- (2016) Caterina Lapenta et al. JOURNAL OF IMMUNOLOGY
- A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
- (2015) T. E. Witzig et al. ANNALS OF ONCOLOGY
- Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas
- (2015) E. A. Chong et al. CLINICAL CANCER RESEARCH
- Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
- (2015) Thanh-Nhan Nguyen-Pham et al. JOURNAL OF IMMUNOTHERAPY
- Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
- (2015) Carmela Rozera et al. Journal of Translational Medicine
- The Role of Angiogenesis in Human Non-Hodgkin Lymphomas
- (2015) Domenico Ribatti et al. NEOPLASIA
- Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
- (2014) Arne Kolstad et al. BLOOD
- Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients
- (2014) A. Busch et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas
- (2013) Tahamtan Ahmadi et al. CANCER
- Lenalidomide Inhibits Lymphangiogenesis in Preclinical Models of Mantle Cell Lymphoma
- (2013) K. Song et al. CANCER RESEARCH
- The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity
- (2013) Patricia Amé-Thomas et al. SEMINARS IN CANCER BIOLOGY
- Immune Monitoring in Cancer Vaccine Clinical Trials: Critical Issues of Functional Flow Cytometry-Based Assays
- (2013) Iole Macchia et al. Biomed Research International
- Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis
- (2012) Frédéric Mourcin et al. Frontiers in Immunology
- IFN- enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing
- (2011) F. Spadaro et al. BLOOD
- Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial
- (2011) E. Kneppers et al. BLOOD
- Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia
- (2011) Bang-Ning Lee et al. CANCER
- Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling
- (2011) G Epron et al. LEUKEMIA
- Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma
- (2011) Karthick Raja Muthu Raja et al. LEUKEMIA & LYMPHOMA
- Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12
- (2011) Stefano M. Santini et al. PLoS One
- IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity
- (2010) Laura Lattanzi et al. IMMUNOBIOLOGY
- Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
- (2009) A. G. Ramsay et al. BLOOD
- Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
- (2009) M Lioznov et al. BONE MARROW TRANSPLANTATION
- Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- (2008) M. Di Nicola et al. BLOOD
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- (2008) Christine Galustian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
- (2008) A. Tzankov et al. HAEMATOLOGICA
- Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells
- (2008) M C Minnema et al. LEUKEMIA
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now